Marco Wachtel

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 25

Top Topics

Skeletal Muscle

Tyrosine Kinase

Papillary Thyroid

Top Venues

Nature communications

Molecular cancer therapeutics

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Fabian F Pusch, Heathcliff Dorado Garcia, Robin Xu, Dennis Gurgen, Yi Bei, Lotte Brueckner, Claudia Röefzaad, Jennifer von Stebut, Victor Bardinet, Rocio Chamorro González, Angelika Eggert, Johannes Hubertus Schulte, Patrick Hundsdörfer, Georg Seifert, Kerstin Haase, Beat W Schäfer, Marco Wachtel, Anja A Kühl, Michael V Ortiz, Antje M Wengner, Monika Scheer, Anton G Henssen
Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models. Molecular cancer therapeutics 23 (4) (2024)
Marco Wachtel, Didier Surdez, Thomas G P Grünewald, Beat W Schäfer
Functional Classification of Fusion Proteins in Sarcoma. Cancers 16 (7) (2024)
Fabian F Pusch, Heathcliff Dorado Garcia, Robin Xu, Dennis Gurgen, Yi Bei, Lotte Brueckner, Claudia Röefzaad, Jennifer von Stebut, Victor Bardinet, Rocio Chamorro González, Angelika Eggert, Johannes Hubertus Schulte, Patrick Hundsdörfer, Georg Seifert, Kerstin Haase, Beat W Schäfer, Marco Wachtel, Anja A Kühl, Michael V Ortiz, Antje M Wengner, Monika Scheer, Anton G Henssen
Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models. Molecular cancer therapeutics 23 (4) (2024)
Sara G Danielli, Jakob Wurth, Sarah Morice, Samanta Kisele, Didier Surdez, Olivier O Delattre, Peter Karl Bode, Marco Wachtel, Beat W Schäfer
Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer. Molecular cancer therapeutics 23 (6) (2024)
Sara G Danielli, Jakob Wurth, Sarah Morice, Samanta Kisele, Didier Surdez, Olivier O Delattre, Peter Karl Bode, Marco Wachtel, Beat W Schäfer
Evaluation of the role of AXL in fusion-positive pediatric rhabdomyosarcoma identifies the small-molecule inhibitor bemcentinib (BGB324) as potent chemosensitizer. Molecular cancer therapeutics (2024)
Sara G Danielli, Jakob Wurth, Sarah Morice, Samanta Kisele, Didier Surdez, Olivier O Delattre, Peter Karl Bode, Marco Wachtel, Beat W Schäfer
Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer. Molecular cancer therapeutics 23 (6) (2024)
Sara G Danielli, Jakob Wurth, Sarah Morice, Samanta Kisele, Didier Surdez, Olivier O Delattre, Peter Karl Bode, Marco Wachtel, Beat W Schäfer
Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer. Molecular cancer therapeutics 23 (6) (2024)
Sara G Danielli, Yun Wei, Michael A Dyer, Elizabeth A Stewart, Heather S Sheppard, Marco Wachtel, Beat W Schäfer, Anand G Patel, David M Langenau
Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma. Nature communications 15 (1) (2024)
Marco Wachtel, Didier Surdez, Thomas G P Grünewald, Beat W Schäfer
Functional Classification of Fusion Proteins in Sarcoma. Cancers 16 (7) (2024)
Sara G Danielli, Jakob Wurth, Sarah Morice, Samanta Kisele, Didier Surdez, Olivier O Delattre, Peter Karl Bode, Marco Wachtel, Beat W Schäfer
Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer. Molecular cancer therapeutics 23 (6) (2024)
Marco Wachtel, Didier Surdez, Thomas G P Grünewald, Beat W Schäfer
Functional Classification of Fusion Proteins in Sarcoma. Cancers 16 (7) (2024)
Sara G Danielli, Yun Wei, Michael A Dyer, Elizabeth A Stewart, Heather S Sheppard, Marco Wachtel, Beat W Schäfer, Anand G Patel, David M Langenau
Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma. Nature communications 15 (1) (2024)
Sara G Danielli, Yun Wei, Michael A Dyer, Elizabeth A Stewart, Heather S Sheppard, Marco Wachtel, Beat W Schäfer, Anand G Patel, David M Langenau
Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma. Nature communications 15 (1) (2024)
Fabian F Pusch, Heathcliff Dorado Garcia, Robin Xu, Dennis Gurgen, Yi Bei, Lotte Brueckner, Claudia Röefzaad, Jennifer von Stebut, Victor Bardinet, Rocio Chamorro González, Angelika Eggert, Johannes Hubertus Schulte, Patrick Hundsdörfer, Georg Seifert, Kerstin Haase, Beat W Schäfer, Marco Wachtel, Anja A Kühl, Michael V Ortiz, Antje M Wengner, Monika Scheer, Anton G Henssen
Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models. Molecular cancer therapeutics 23 (4) (2024)
Yaw Asante, Katharina Benischke, Issra Osman, Quy A Ngo, Jakob Wurth, Dominik Laubscher, Hyun Min Kim, Bhavatharini Udhayakumar, Md Imdadul H Khan, Diana H Chin, Jadon Porch, Maharshi Chakraborty, Richard Sallari, Olivier O Delattre, Sakina Zaidi, Sarah Morice, Didier Surdez, Sara G Danielli, Beat W Schäfer, Berkley E Gryder, Marco Wachtel
PAX3-FOXO1 uses its activation domain to recruit CBP/P300 and shape RNA Pol2 cluster distribution. Nature communications 14 (1) (2023)
Silvia Pomella, Matteo Cassandri, Lucrezia D'Archivio, Antonella Porrazzo, Cristina Cossetti, Doris Phelps, Clara Perrone, Michele Pezzella, Antonella Cardinale, Marco Wachtel, Sara Aloisi, David Milewski, Marta Colletti, Prethish Sreenivas, Zoë S Walters, Giovanni Barillari, Angela Di Giannatale, Giuseppe Maria Milano, Cristiano De Stefanis, Rita Alaggio, Sonia Rodriguez-Rodriguez, Nadia Carlesso, Christopher R Vakoc, Enrico Velardi, Beat W Schäfer, Ernesto Guccione, Susanne Andrea Gatz, Ajla Wasti, Marielle Yohe, Myron S Ignatius, Concetta Quintarelli, Janet M Shipley, Lucio Miele, Javed Khan, Peter J Houghton, Francesco Marampon, Berkley E Gryder, Biagio De Angelis, Franco Locatelli, Rossella Rota
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57 Kip2 targeting. Nature communications 14 (1) (2023)
Fabian F Pusch, Heathcliff Dorado Garcia, Robin Xu, Dennis Gurgen, Yi Bei, Lotte Brueckner, Claudia Röefzaad, Jennifer von Stebut, Victor Bardinet, Rocio Chamorro González, Angelika Eggert, Johannes Hubertus Schulte, Patrick Hundsdörfer, Georg Seifert, Kerstin Haase, Beat W Schäfer, Marco Wachtel, Anja A Kühl, Michael V Ortiz, Antje M Wengner, Monika Scheer, Anton G Henssen
Elimusertib has anti-tumor activity in preclinical patient-derived pediatric solid tumor models. Molecular cancer therapeutics (2023)
Yaw Asante, Katharina Benischke, Issra Osman, Quy A Ngo, Jakob Wurth, Dominik Laubscher, Hyun Min Kim, Bhavatharini Udhayakumar, Md Imdadul H Khan, Diana H Chin, Jadon Porch, Maharshi Chakraborty, Richard Sallari, Olivier O Delattre, Sakina Zaidi, Sarah Morice, Didier Surdez, Sara G Danielli, Beat W Schäfer, Berkley E Gryder, Marco Wachtel
PAX3-FOXO1 uses its activation domain to recruit CBP/P300 and shape RNA Pol2 cluster distribution. Nature communications 14 (1) (2023)
Joana G Marques, Blaz Pavlovic, Quy A Ngo, Gloria Pedot, Michaela Roemmele, Larissa Volken, Samanta Kisele, Romain Perbet, Marco Wachtel, Beat W Schäfer
The chromatin remodeler CHD4 sustains Ewing Sarcoma cell survival by controlling global chromatin architecture. Cancer research (2023)
Fabian F Pusch, Heathcliff Dorado Garcia, Robin Xu, Dennis Gurgen, Yi Bei, Lotte Brueckner, Claudia Röefzaad, Jennifer von Stebut, Victor Bardinet, Rocio Chamorro González, Angelika Eggert, Johannes Hubertus Schulte, Patrick Hundsdörfer, Georg Seifert, Kerstin Haase, Beat W Schäfer, Marco Wachtel, Anja A Kühl, Michael V Ortiz, Antje M Wengner, Monika Scheer, Anton G Henssen
Elimusertib has anti-tumor activity in preclinical patient-derived pediatric solid tumor models. Molecular cancer therapeutics (2023)
Silvia Pomella, Matteo Cassandri, Lucrezia D'Archivio, Antonella Porrazzo, Cristina Cossetti, Doris Phelps, Clara Perrone, Michele Pezzella, Antonella Cardinale, Marco Wachtel, Sara Aloisi, David Milewski, Marta Colletti, Prethish Sreenivas, Zoë S Walters, Giovanni Barillari, Angela Di Giannatale, Giuseppe Maria Milano, Cristiano De Stefanis, Rita Alaggio, Sonia Rodriguez-Rodriguez, Nadia Carlesso, Christopher R Vakoc, Enrico Velardi, Beat W Schäfer, Ernesto Guccione, Susanne Andrea Gatz, Ajla Wasti, Marielle Yohe, Myron S Ignatius, Concetta Quintarelli, Janet M Shipley, Lucio Miele, Javed Khan, Peter J Houghton, Francesco Marampon, Berkley E Gryder, Biagio De Angelis, Franco Locatelli, Rossella Rota
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57 Kip2 targeting. Nature communications 14 (1) (2023)
Silvia Pomella, Matteo Cassandri, Lucrezia D'Archivio, Antonella Porrazzo, Cristina Cossetti, Doris Phelps, Clara Perrone, Michele Pezzella, Antonella Cardinale, Marco Wachtel, Sara Aloisi, David Milewski, Marta Colletti, Prethish Sreenivas, Zoë S Walters, Giovanni Barillari, Angela Di Giannatale, Giuseppe Maria Milano, Cristiano De Stefanis, Rita Alaggio, Sonia Rodriguez-Rodriguez, Nadia Carlesso, Christopher R Vakoc, Enrico Velardi, Beat W Schäfer, Ernesto Guccione, Susanne Andrea Gatz, Ajla Wasti, Marielle Yohe, Myron S Ignatius, Concetta Quintarelli, Janet M Shipley, Lucio Miele, Javed Khan, Peter J Houghton, Francesco Marampon, Berkley E Gryder, Biagio De Angelis, Franco Locatelli, Rossella Rota
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57 Kip2 targeting. Nature communications 14 (1) (2023)
Silvia Pomella, Sara G Danielli, Rita Alaggio, Willemijn B Breunis, Ebrahem Hamed, Joanna Selfe, Marco Wachtel, Zoe S Walters, Beat W Schäfer, Rossella Rota, Janet M Shipley, Simone Hettmer
Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma. Cancers 15 (10) (2023)
Silvia Pomella, Matteo Cassandri, Lucrezia D'Archivio, Antonella Porrazzo, Cristina Cossetti, Doris Phelps, Clara Perrone, Michele Pezzella, Antonella Cardinale, Marco Wachtel, Sara Aloisi, David Milewski, Marta Colletti, Prethish Sreenivas, Zoë S Walters, Giovanni Barillari, Angela Di Giannatale, Giuseppe Maria Milano, Cristiano De Stefanis, Rita Alaggio, Sonia Rodriguez-Rodriguez, Nadia Carlesso, Christopher R Vakoc, Enrico Velardi, Beat W Schäfer, Ernesto Guccione, Susanne Andrea Gatz, Ajla Wasti, Marielle Yohe, Myron S Ignatius, Concetta Quintarelli, Janet M Shipley, Lucio Miele, Javed Khan, Peter J Houghton, Francesco Marampon, Berkley E Gryder, Biagio De Angelis, Franco Locatelli, Rossella Rota
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57 Kip2 targeting. Nature communications 14 (1) (2023)
Yaw Asante, Katharina Benischke, Issra Osman, Quy A Ngo, Jakob Wurth, Dominik Laubscher, Hyun Min Kim, Bhavatharini Udhayakumar, Md Imdadul H Khan, Diana H Chin, Jadon Porch, Maharshi Chakraborty, Richard Sallari, Olivier O Delattre, Sakina Zaidi, Sarah Morice, Didier Surdez, Sara G Danielli, Beat W Schäfer, Berkley E Gryder, Marco Wachtel
PAX3-FOXO1 uses its activation domain to recruit CBP/P300 and shape RNA Pol2 cluster distribution. Nature communications 14 (1) (2023)